Immunohistochemistry for the HIF1α-inducible proteins CA9 and Glut1, and for HIF1α itself, revealed moderate or strong expression of at least one of these markers in all but two of the tumours, verifying the well-described hypoxic signature associated with loss of function of pVHL. This evidence concerns the gene SLC2A1 and neoplasm.